Validating the Simplified Endoscopic Mucosal Assessment for Crohn’s Disease
Validating the Simplified Endoscopic Mucosal Assessment for Crohn’s Disease: A Novel Method for Assessing Disease Activity. Jeremy Adler,...
top of page
The Mission
Key Opinion Leaders
International
Advisory Board
Initiatives
Discuss a case
Journal Scan
Latest News
Education Hub
Gallery
IBDENC ENC
- Oct 18, 2022
Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients
Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study,...
IBDENC ENC
- Oct 14, 2022
Pregnancy outcomes in inflammatory bowel disease: Data from a large cohort survey
Tommaso Innocenti, Jenny Roselli, Alice Taylor, Gabriele Dragoni, Erica Nicola Lynch, Claudia Campani, Matteo Gottin, Siro Bagnoli,...
IBDENC ENC
- Oct 13, 2022
Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel
Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases. Chloé Michaudel, Camille...
IBDENC ENC
- Oct 8, 2022
Rapid infusion of infliximab biosimilars and the incidence and severity of infusion-related reaction
Rapid infusion of infliximab biosimilars and the incidence and severity of infusion-related reactions in patients with inflammatory bowel...
IBDENC ENC
- Oct 4, 2022
The diagnostic yield of pan-enteric capsule endoscopy in inflammatory bowel disease
The diagnostic yield of pan-enteric capsule endoscopy in inflammatory bowel disease: A systematic review and meta-analysis. Aravind Gokul...
IBDENC ENC
- Sep 30, 2022
Transcriptional Behavior of Regulatory T Cells Predicts IBD Patient Responses to Vedolizumab Therapy
Maria T Abreu, Julie M Davies, Maria A Quintero, Amber Delmas, Sophia Diaz, Catherine D Martinez, Thomas Venables , Adrian Reich, Gogce...
IBDENC ENC
- Sep 27, 2022
Helicobacter bilis Contributes to the Occurrence of Inflammatory Bowel Disease
Helicobacter bilis Contributes to the Occurrence of Inflammatory Bowel Disease by Inducing Host Immune Disorders. Wei Peng, Xinhua Zhao,...
IBDENC ENC
- Sep 23, 2022
Definition of mild to moderate ulcerative colitis in clinical trials: A systematic literature review
Bénédicte Caron, Vipul Jairath, Ferdinando D'Amico, Kristine Paridaens, Fernando Magro, Silvio Danese, Laurent Peyrin-Biroulet Published...
IBDENC ENC
- Sep 22, 2022
An autologous colonic organoid-derived monolayer model to study immune
An autologous colonic organoid-derived monolayer model to study immune: bacterial interactions in Crohn's disease patients. Hamish CK...
IBDENC ENC
- Sep 17, 2022
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from...
IBDENC ENC
- Sep 14, 2022
Colorectal cancer in elderly-onset inflammatory bowel disease
Colorectal cancer in elderly-onset inflammatory bowel disease: a 1969–2017 Scandinavian register-based cohort study. Åsa H Everhov, Rune...
bottom of page